Shukra Pharmaceuticals Limited

Web: shukrapharmaceuticals.com NSE: SHUKRAPHAR BSE: 524632 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

52 1(1%)

Near 52W High of 56

Volume

Open

112

High

118

Low

107

VWAP

52 Week High

52 Week Low

Viand Research Rating

Quality Score

77/100

Growth Score

100/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

2,303

No. of Shares

44.1

P/E

18.8

P/B

4.71

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

25.04

ROCE

Profit Growth

Listing Date

Promoter Holding

51.16%

FII Holding

DII Holding

0.11%

Price Chart

Price Performance

1 Week0

1 Month0

3 Months0

6 Months0

1 Year0

YTD0

Moving Average

5 Day SMA0

10 Day SMA0

20 Day SMA0

30 Day SMA0

50 Day SMA0

61 Day SMA0

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3
Resistance 2
Resistance 1
Pivot Point
Support 1
Support 2
Support 3

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Aug 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(0.21) 51.16%	(0.01) 50.95%	(0.01) 50.95%	(0.01) 50.95%	(0.01) 50.95%	(0.01) 50.95%	(0.01) 50.95%	(0.01) 50.95%	(0.01) 50.95%	(0.01) 50.95%	(0.01) 50.95%	(0.11) 50.95%	(0.01) 50.90%	(0.01) 50.90%	(1.71) 50.90%	(0.01) 49.16%	(0.01) 49.16%	(0.01) 49.17%	(0.01) 49.17%	(0.01) 49.17%
DIIs	(0.01) 0.11%	(0.01) 0.11%	(0.01) 0.11%	(0.01) 0.11%	(0.01) 0.11%	(0.01) 0.11%	(0.01) 0.11%	(0.01) 0.11%	(0.01) 0.11%	(0.01) 0.11%	(0.01) 0.11%	(0.01) 0.11%	(0.01) 0.11%	(0.01) 0.11%	(-0.71) 0.11%	(0.01) 0.80%	(0.01) 0.80%	(0.01) 0.80%	(0.01) 0.80%	(0.01) 0.80%
Public	48.74%	48.93%	48.92%	48.93%	48.93%	48.93%	48.93%	48.93%	48.93%	48.93%	48.93%	48.93%	48.99%	48.99%	48.99%	50.04%	50.04%	50.04%	50.04%	50.04%
No. of Shareholders	28,384	28,384	27,173	25,649	21,441	20,337	18,231	17,844	16,321	14,989	12,974	10,963	9,747	9,582	9,531	9,234	9,237	9,193	9,239	9,268

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	24	6	39	6	5	13	11	5.56	3.18	10.88	18.89	24.64	20.16	46.25	2.3	3.72	6.57	8.94	2.89	2.98
Sales Growth % (YoY)	336%	-52%	270%	-	-	-	-	-77.4%	-84.2%	-76.5%	721.3%	562.4%	206.8%	417.3%	-20.4%	24.8%	122%	109.9%	-30.4%	77%
Sales Growth % (QoQ)	300%	-84.6%	550%	20%	-61.5%	18.2%	97.8%	74.8%	-70.8%	-42.4%	-23.3%	22.2%	-56.4%	1910.9%	-38.2%	-43.4%	-26.5%	209.3%	-3%	-
Expenses	4	6	12	6	4	6	7	4.9	2.38	6.45	9.34	19.55	19.82	42.6	2.02	3.25	5.61	7.36	2.52	4.92
Operating Profit	19	1	27	0	1	7	4	0.66	0.8	4.43	9.55	5.09	0.34	3.65	0.28	0.47	0.96	1.58	0.37	-1.94
OPM %	81	11	69	-7	24	55	37	11.87	25.16	40.72	50.56	20.66	1.69	7.89	12.17	12.63	14.61	17.67	12.8	-65.1
Other Income	1	1	1	2	1	1	1	1.02	0.72	1.38	0.56	0.24	0.63	0.89	0.27	0.03	0.01	0.04	0.13	2.4
Interest	0	0	0	0	0	0	0	0.11	0.06	0.07	0.07	0.06	0.08	0.07	0.05	0.04	0.12	0.21	0.04	0.02
Depreciation	1	1	1	1	1	1	1	0.7	0.67	0.52	0.51	0.56	0.46	0.51	0.46	0.45	0.42	0.56	0.37	0.37
Profit before tax	18	0	27	0	1	8	4	0.87	0.79	5.22	9.53	4.71	0.43	3.96	0.04	0.01	0.43	0.85	0.09	0.07
Tax %	29	553	24	-1090	26	29	23	39.08	40.51	23.75	1.05	-0.21	2.33	-0.25	50	-700	23.26	23.53	44.44	85.71
Net Profit	13	-2	20	2	1	5	3	0.54	0.49	3.99	9.42	4.71	0.42	3.98	0.03	0.08	0.33	0.65	0.05	0.02
Net Profit Growth % (QoQ)	750%	-110%	900%	100%	-80%	66.7%	455.6%	10.2%	-87.7%	-57.6%	100%	1021.4%	-89.4%	13166.7%	-62.5%	-75.8%	-49.2%	1200%	150%	-
Net Profit Growth % (YoY)	1200%	-140%	566.7%	270.4%	104.1%	25.3%	-68.2%	-88.5%	16.7%	0.3%	31300%	5787.5%	27.3%	512.3%	-40%	300%	-	-	-	-
TTM Net Profit	33	21	28	11	9.54	9.03	8.02	14.44	18.61	18.54	18.53	9.14	4.51	4.42	1.09	1.11	1.05	0.72	0.07	0
EPS in Rs	0.29	-0.04	0.46	0.05	0.02	0.12	0.07	0.01	0.01	0.09	0.22	0.11	0.01	0.09	0	0	0.01	0.01	0	0

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	57	33	75	59	20	11	12	6	5	5	5	3	4	5.11
Sales Growth %	74%	-	27%	187%	83%	-6%	109%	6%	4%	7%	85%	-41%	-13%	-22.9%
Expenses	28	20	55	53	18	10	10	4	4	4	4	3	5	4.63
Operating Profit	29	13	19	5	3	1	2	2	2	1	1	0	0	0.48
OPM %	51	39	26	9	14	13	13	29	30	28	24	-10	-2	9.39
Other Income	5	4	3	1	0	0	0	0	0	0	0	1	0	-2.65
Interest	1	1	0	0	0	0	0	0	0	0	0	0	0	0.03
Depreciation	3	3	2	2	2	1	1	1	1	0	0	1	1	0.73
Profit before tax	29	13	20	4	1	0	0	1	1	1	0	0	-1	-2.93
Tax %	23	28	7	1	26	-90	82	37	45	52	66	52	9	0
Net Profit	22	10	19	4	1	0	0	0	1	0	0	0	-1	-2.93
Net Profit Growth %	120%	-47.4%	375%	300%	-	-	-	-100%	-	-	-	100%	65.9%	-
EPS in Rs	0.5	0.22	0.42	0.1	0.02	0	0	0.01	0.01	0.01	0	0	-0.02	-0.01
Dividend Payout %	2	0	6	4	10	0	0	17	15	16	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	4	8	-5	3	8	1	1	0	1	0	3	-2	-3	-12.12
Cash from Investing Activity	-14	-1	-1	-4	-2	-2	-3	-2	-5	-1	0	1	-10	1.7
Cash from Financing Activity	4	-5	12	5	-7	2	2	2	3	0	-1	1	-18	5.25
Net Cash Flow	-6	2	6	4	0	0	0	0	0	-1	1	0	-31	-5.17

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	44	44	44	43.79	11	4	2	2	2	2	2	2	2	2	2	10.17
Reserves	46	22	19	10.5	47	21	15	14	14	14	13	13	13	12	12	-10.6
Borrowings	5	4	4	2.73	3	5	3	10	8	6	4	0	0	1	0	10.12
Other Liabilities	23	18	20	23.65	17	45	15	10	10	7	6	4	3	3	4	3.9
Total Liabilities	117	87	87	80.67	78	75	35	36	34	28	24	19	17	18	18	13.59
Fixed Assets	22	19	19	19.69	20	20	18	18	17	16	14	10	10	10	10	10.13
CWIP	12	2	2	1.66	2	2	2	2	2	2	2	2	2	2	2	0.05
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.01
Other Assets	84	66	65	59.32	56	53	16	16	14	11	8	7	6	7	7	3.4
Total Assets	117	87	87	80.67	78	75	35	36	34	28	24	19	17	18	18	13.59

Delivery

Delivery Data: SHUKRAPHAR

#	Date	40 39% 56	Value (Cr)	Q/T 397	Del 53	Del 9
1	4-Sep	52	22	296	38	8
2	3-Sep	52	46	303	36	16
3	2-Sep	47	14	419	43	6
4	1-Sep	44	8	529	70	6
5	31-Aug	44	7	496	42	3
6	28-Aug	44	4	523	54	2
7	27-Aug	44	4	446	66	3
8	26-Aug	44	11	603	50	5
9	25-Aug	44	6	649	59	4
10	24-Aug	44	3	317	71	2
11	21-Aug	44	5	400	55	3
12	20-Aug	43	2	152	63	1
13	19-Aug	43	4	334	44	2
14	18-Aug	42	5	545	63	3
15	17-Aug	41	5	243	71	3
16	14-Aug	41	5	145	39	2

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	2,303c	25c	1.08
03-Sep	2,279c	284c	14.21
01-Sep	1,995c	16c	0.80
31-Aug	1,979c	13c	0.67
26-Aug	1,966c	22c	1.15
25-Aug	1,944c	6c	0.32
24-Aug	1,937c	25c	1.31
21-Aug	1,912c	33c	1.75
19-Aug	1,879c	55c	2.99
18-Aug	1,825c	44L	0.02
17-Aug	1,824c	22c	1.22
14-Aug	1,802c	0	0

Stock Checklist

Price is above from 52 week high low average: 80%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: NO

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: YES

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView